Wayne Holman

1.3k total citations · 2 hit papers
9 papers, 556 citations indexed

About

Wayne Holman is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Wayne Holman has authored 9 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Wayne Holman's work include SARS-CoV-2 and COVID-19 Research (5 papers), Respiratory viral infections research (5 papers) and SARS-CoV-2 detection and testing (3 papers). Wayne Holman is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Respiratory viral infections research (5 papers) and SARS-CoV-2 detection and testing (3 papers). Wayne Holman collaborates with scholars based in Australia, United States and United Kingdom. Wayne Holman's co-authors include Laura J. Szewczyk, Wendy Painter, Jim Bush, Firas Almazedi, George R. Painter, Merribeth J. Morin, William A. Fischer, Katyna Borroto–Esoda, Joseph J. Eron and Masoud Azizad and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Wayne Holman

8 papers receiving 526 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2

2021 274 citations Wendy Painter, Wayne Holman et al. Antimicrobial Agents and Chemotherapy profile →
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

2021 230 citations William A. Fischer, Joseph J. Eron et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wayne Holman Australia	6	427	127	75	72	60	9	556
Laura J. Szewczyk United States	3	420 1.0×	122 1.0×	73 1.0×	70 1.0×	58 1.0×	3	506
James Logue United States	11	423 1.0×	60 0.5×	94 1.3×	49 0.7×	60 1.0×	21	554
Soonju Park South Korea	8	377 0.9×	102 0.8×	121 1.6×	51 0.7×	116 1.9×	10	573
Julie Blaising France	7	305 0.7×	195 1.5×	130 1.7×	73 1.0×	45 0.8×	8	638
Gitanjali Subramanya United States	7	438 1.0×	231 1.8×	114 1.5×	71 1.0×	62 1.0×	8	793
Blandine Padey France	10	317 0.7×	196 1.5×	107 1.4×	58 0.8×	57 0.9×	14	537
Ronza Najjar‐Debbiny Israel	8	440 1.0×	90 0.7×	53 0.7×	183 2.5×	23 0.4×	22	602
Leila Mousavizadeh Iran	4	485 1.1×	41 0.3×	145 1.9×	99 1.4×	76 1.3×	9	679
L Chiappa Italy	2	188 0.4×	120 0.9×	62 0.8×	49 0.7×	30 0.5×	3	342
Zehan Pang China	7	283 0.7×	65 0.5×	120 1.6×	36 0.5×	27 0.5×	7	447

Countries citing papers authored by Wayne Holman

Since Specialization

Citations

This map shows the geographic impact of Wayne Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Holman more than expected).

Fields of papers citing papers by Wayne Holman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Holman. The network helps show where Wayne Holman may publish in the future.

Co-authorship network of co-authors of Wayne Holman

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne Holman. A scholar is included among the top collaborators of Wayne Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne Holman. Wayne Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Chawla, Akshita, Ruthie Birger, Brian M. Maas, et al.. (2025). Comparison of Molnupiravir Exposure‐Response Relationships for Virology Response and Mechanism of Action Biomarkers With Clinical Outcomes in Treatment of COVID‐19. Clinical and Translational Science. 18(4). e70184–e70184.

2.

Fitzgerald, Richard J., Laura Dickinson, Laura Else, et al.. (2022). Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clinical Infectious Diseases. 75(1). e525–e528. 14 indexed citations

3.

Azizad, Masoud, Cameron R. Wolfe, Amy James Loftis, et al.. (2022). A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. UNC Libraries. 2 indexed citations

4.

Fischer, William A., Joseph J. Eron, Wayne Holman, et al.. (2021). A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Science Translational Medicine. 14(628). eabl7430–eabl7430. 230 indexed citations breakdown →

5.

Painter, Wendy, Wayne Holman, Jim Bush, et al.. (2021). Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2. Antimicrobial Agents and Chemotherapy. 65(5). 274 indexed citations breakdown →

6.

Brenk, H.A.S. van den, et al.. (1959). Studies of the Effect of a Colloidal Radioactive Chromic Phosphate (Cr32PO4) in Clinical and Experimental Malignant Effusions. British Journal of Cancer. 13(2). 181–194. 12 indexed citations

7.

Holman, Wayne, et al.. (1956). TREATMENT OF THYROTOXICOSIS WITH RADIOACTIVE IODINE (I ²³¹ ). The Medical Journal of Australia. 2(19). 701–710. 6 indexed citations

8.

Holman, Wayne, et al.. (1953). X-ray irradiation and conservative surgery in the treatment of chronic duodenal ulcer. Journal of the Faculty of Radiologists. 5(1). 42–49. 5 indexed citations

9.

Holman, Wayne, et al.. (1952). ANTRODUODENECTOMY AND X-RAY IRRADIATION IN THE TREATMENT OF DUODENAL ULCER. The Lancet. 260(6746). 1145–1149. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact